SRL Diagnostics launches ‘Heart Assure Test’ to predict risk of cardiac event
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
Patients with moderate or elevated risk in the test should immediately consult a cardiologist for further diagnosis and workup
‘PathoDetect HPV Detection Test’ detects and discriminates the presence of high-risk HPV strains including 16 and 18 which cause most of the cervical cancers.
One in two women with advanced ovarian cancer has an HRD-positive tumor
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
The Phase 3 SOLO-1 trial demonstrated 67% of advanced ovarian cancer patients with BRCA mutations receiving LYNPARZA were alive at seven years versus 47% of placebo patients
India is at the forefront of research in cardiology worldwide but making indigenous products is what we are lacking & it needs to be improved
Philips AI-powered interventional and diagnostic smart systems enhances diagnostic confidence, drive greater efficiency, and improve patient outcomes
Subscribe To Our Newsletter & Stay Updated